As of 2025-11-01, the EV/EBITDA ratio of Moderna Inc (MRNA) is -3.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 9,388.15 mil USD. MRNA's TTM EBITDA according to its financial statements is -2,576.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 13.6x | 12.0x |
| Forward P/E multiples | 9.9x - 12.8x | 11.8x |
| Fair Price | (70.74) - (81.56) | (75.20) |
| Upside | -360.5% - -400.3% | -376.9% |
| Date | EV/EBITDA |
| 2025-10-31 | -3.64 |
| 2025-10-30 | -3.79 |
| 2025-10-29 | -3.27 |
| 2025-10-28 | -3.37 |
| 2025-10-27 | -3.57 |
| 2025-10-24 | -3.58 |
| 2025-10-23 | -3.51 |
| 2025-10-22 | -3.60 |
| 2025-10-21 | -3.69 |
| 2025-10-20 | -3.66 |
| 2025-10-17 | -3.47 |
| 2025-10-16 | -3.64 |
| 2025-10-15 | -3.73 |
| 2025-10-14 | -3.51 |
| 2025-10-13 | -3.58 |
| 2025-10-10 | -3.59 |
| 2025-10-09 | -3.70 |
| 2025-10-08 | -3.76 |
| 2025-10-07 | -3.67 |
| 2025-10-06 | -3.70 |
| 2025-10-03 | -3.85 |
| 2025-10-02 | -3.83 |
| 2025-10-01 | -3.71 |
| 2025-09-30 | -3.44 |
| 2025-09-29 | -3.37 |
| 2025-09-26 | -3.24 |
| 2025-09-25 | -3.26 |
| 2025-09-24 | -3.45 |
| 2025-09-23 | -3.44 |
| 2025-09-22 | -3.55 |
| 2025-09-19 | -3.35 |
| 2025-09-18 | -3.39 |
| 2025-09-17 | -3.32 |
| 2025-09-16 | -3.29 |
| 2025-09-15 | -3.15 |
| 2025-09-12 | -3.09 |
| 2025-09-11 | -3.38 |
| 2025-09-10 | -3.21 |
| 2025-09-09 | -3.24 |
| 2025-09-08 | -3.29 |
| 2025-09-05 | -3.34 |
| 2025-09-04 | -3.21 |
| 2025-09-03 | -3.17 |
| 2025-09-02 | -3.19 |
| 2025-08-29 | -3.18 |
| 2025-08-28 | -3.24 |
| 2025-08-27 | -3.33 |
| 2025-08-26 | -3.28 |
| 2025-08-25 | -3.37 |
| 2025-08-22 | -3.64 |